Intravenous warfarin as an alternative for anticoagulation

Pharmacotherapy

Volumn 27, Issue 6, 2007, Pages 933-935

  Gellatly, Rochelle M ^a,b  

^a FRASER HEALTH AUTHORITY   (Canada)

^b ROYAL COLUMBIAN HOSPITAL   (Canada)

Author keywords

Crohn's disease; Deep vein thrombosis; Intravenous; Resistance; Warfarin

Indexed keywords

HEPARIN; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CAUCASIAN; CENTRAL VENOUS CATHETER; COLON RESECTION; CROHN DISEASE; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; PYODERMA GANGRENOSUM; THROMBOSIS;

ADMINISTRATION, ORAL; ADULT; ANTICOAGULANTS; ARM; CROHN DISEASE; DRUG RESISTANCE; FEMALE; HEPARIN; HUMANS; INJECTIONS, INTRAVENOUS; INTERNATIONAL NORMALIZED RATIO; ULTRASONOGRAPHY, DOPPLER; VENOUS THROMBOSIS; WARFARIN;

EID: 34249816495     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.27.6.933     Document Type: Article

References (9)

1. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. The seventh ACCP conference on antithrombotic and thrombolytic therapy: antithrombotic therapy for venous thromboembolic disease. Chest 2004;126(3):401S-28.
2. DiDomenico RJ. Coagulants and anticoagulants. In: Anderson PO, Knoben JE, Troutman WG, eds. Handbook of clinical drug data, 10th ed. New York: McGraw-Hill Companies, Inc., 2002:615-17.
3. Porter RS, Sawyer WT. Warfarin. In: Evans WE, Schentag JJ, Jusko WJ, eds. Applied pharmacokinetics: principles of therapeutic drug monitoring, 3rd ed. Vancouver, WA: Applied Therapeutics, Inc., 1992:31-1-31-46.
4. Brophy DF, Ford SL, Crouch MA. Warfarin resistance in a patient with short bowel syndrome. Pharmacotherapy 1998;18(3):646-9.
5. Hulse ML. Warfarin resistance: diagnosis and therapeutic alternatives. Pharmacotherapy 1996;16(6):1009-17.
6. Brystol-Myers Squibb Canada, Inc. Coumadin (warfarin sodium) product monograph. Montreal, Quebec, Canada; 2005.
7. Wolff JM, Barker NW, Gifford RW, Mann FD. Experience with a new intravenous coumarin anticoagulant (warfarin, sodium derivative). Mayo Clin Proc 1953;28(18):489-97.
8. Shapiro S. Warfarin sodium derivative (coumadin sodium): an intravenous hypoprothrombinemia-inducing agent. Angiology 1953;4(4):380-90.
9. O'Reilly RA, Wellin PG, Wagner JG. Pharmacokinetics of warfarin following intravenous administration to man. Thromb Diath Haem 1971;25(1):178-86.